FDA Expands Use of Remdesivir for COVID-19 Treatment
The Federal Drug Administration has broadened its unexpected emergency use authorization for the anti-viral drug remdesivir to incorporate all hospitalized coronavirus clients, not just these who are so ill they call for ventilators or oxygen therapy.
